Motley Fool Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$26.2M Buy
2025
Q1
$24.7M Buy
2024
Q4
$22.7M Sell
2024
Q3
$29.8M Sell
2024
Q2
$36.7M Sell
2024
Q1
$40.1M Sell
2023
Q4
$45.4M Sell
2023
Q3
$43.3M Buy
2023
Q2
$28.6M Sell
2023
Q1
$32.8M Sell
2022
Q4
$35M Sell
2022
Q3
$29.1M Sell
2022
Q2
$28.9M Sell
2022
Q1
$27.5M Buy
2021
Q4
$20.2M Sell
2021
Q3
$18.1M Sell
2021
Q2
$20.1M Sell
2021
Q1
$18.4M Sell
2020
Q4
$21.6M Buy
2020
Q3
$18.6M Buy
2020
Q2
$30M Sell
2020
Q1
$21.2M Sell
2019
Q4
$22.3M Buy